Search Results 1481-1490 of 18962 for DVT

  1. The Kronos Early Estrogen Prevention Study (KEEPS) - Mayo Clinic

    History of thromboembolic disease (deep vein thrombosis or pulmonary embolus). Coronary calcium score ≥ 50 units. History of untreated (no cholecystectomy) ...

  2. Ablation therapy - Doctors & Departments - Mayo Clinic

    ... Deep vein thrombosis, Pulmonary embolism, Hemorrhoids, Cholecystitis, Ureteral obstruction, Peripheral artery disease, Renal cell carcinoma, Claudication ...

  3. Ablation therapy - Doctors & Departments - Mayo Clinic

    ... Deep vein thrombosis, Pulmonary embolism, Hemorrhoids, Cholecystitis, Ureteral obstruction, Peripheral artery disease, Renal cell carcinoma, Claudication ...

  4. Renal artery stenosis - Doctors and departments - Mayo Clinic

    ... Deep vein thrombosis, Vascular malformation, Klippel-Trenaunay syndrome, Aortic valve disease, Thoracic aortic aneurysm, Aortic valve stenosis, Abdominal ...

  5. TMJ disorders - Doctors and departments - Mayo Clinic

    Intensive care, Anticoagulant therapy, Deep vein thrombosis, Congenital hypercoagulability. Jonathan Balog, D.O.. Jacksonville, FL ...

  6. TMJ disorders - Doctors and departments - Mayo Clinic

    Intensive care, Anticoagulant therapy, Deep vein thrombosis, Congenital hypercoagulability. Jonathan Balog, D.O.. Jacksonville, FL ...

  7. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer - Mayo Clinic

    Deep vein thrombosis; Other thromboembolic event. History of brain metastases, spinal cord compression, or carcinomatous meningitis; Of child-bearing potential ...

  8. TMJ disorders - Doctors and departments - Mayo Clinic

    Intensive care, Anticoagulant therapy, Deep vein thrombosis, Congenital hypercoagulability. Jonathan Balog, D.O.. Jacksonville, FL ...

  9. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    Have had arterial or venous thrombotic or embolic events such as cerebrovascular accident (including transient ischemic attacks), deep vein thrombosis, or ...

  10. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

    Evidence of non-catheter related deep vein thrombosis, stroke, myocardial infarction, or arterial embolus within the 3 months before the Day 1 Visit ...